MIT45 markets its products to professionals and creatives seeking energy, focus, or stress relief. The company emphasizes safety and reliability through several key claims:
Their signature "Gold" shot is a concentrated tincture with a 45% mitragynine concentration. MIT45 markets its products to professionals and creatives
Investigative reports have linked highly concentrated extracts, including those from MIT45, to fatal overdoses in Florida when combined with other substances. including those from MIT45
As of March 2024, the company has been the subject of a civil class action lawsuit alleging misleading sales practices and failure to disclose that kratom's active ingredients act on the same receptors as opioids, carrying risks of addiction and withdrawal. carrying risks of addiction and withdrawal.